For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230207:nRSG1549Pa&default-theme=true
RNS Number : 1549P Imperial Brands PLC 07 February 2023
IMPERIAL BRANDS PLC
Legal Entity Identifier (LEI) No. 549300DFVPOB67JL3A42
7 February 2023
BOARD APPOINTMENT
Imperial Brands PLC is pleased to announce that Andrew Gilchrist will join the
Board as a Non-Executive Director, with effect from 1 March 2023.
Andrew, who was Chief Financial Officer of Reynolds American Inc until its
acquisition by British American Tobacco (BAT) in 2017, has two decades of
operational and financial experience in the tobacco sector. At Reynolds,
Andrew held a range of leadership positions, including Chief Information
Officer, Chief Commercial Officer and Business Development Director. Earlier
in his career, he worked for BAT in marketing and planning roles.
Chair Thérèse Esperdy said "I am delighted to welcome Andrew to the Board.
As well as the combination of his commercial and financial experience across
our industry, he has a proven track record of business development, strategic
planning and business integration. These skills and capabilities will further
strengthen the Board's effectiveness, as we continue the transformation of
Imperial Brands."
Andrew will also join the Audit Committee and the People and Governance
Committee with effect from 1 March 2023.
There are no other changes to Committee memberships.
This announcement is made in accordance with LR 9.6.11. Other than as set out
above, there are no further details required to be disclosed under LR 9.6.13
in connection with Andrew's appointment.
ENDS
Investor Contacts Media Contacts
Peter Durman +44 (0)7970 328 903 Jonathan Oliver +44 (0)7740 096 018
Jennifer Ramsey +44 (0)7974 615 739 Simon Evans +44 (0)7967 467 684
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAMZGGZLNMGFZG